Variability in response to antihypertensive drugs

Area of Science:

• Pharmacogenomics
• Cardiovascular Medicine
• Clinical Pharmacology

Background:

• Heterogeneity of treatment effects (HTE) describes how individual responses to a single medication vary within a population.
• Hypertension is a suitable model for studying HTE due to established measurement protocols and known patient-specific influences.
• Patient characteristics like age and race/ethnicity, alongside genetic factors, impact blood pressure regulation and response to antihypertensive drugs.

Purpose of the Study:

• To explore the sources of variability in antihypertensive treatment response.
• To highlight the role of pharmacogenetics in understanding HTE in hypertension.
• To emphasize the importance of understanding HTE for clinical practice and research.

Main Methods:

• Review of existing literature on HTE in hypertension.
• Analysis of patient characteristics influencing blood pressure.
• Examination of pharmacogenetic polymorphisms within the renin-angiotensin-aldosterone system (RAAS).

Main Results:

• Standardized measurement techniques reduce variability from clinical assessments.
• Patient demographics (age, race/ethnicity) are significant factors in blood pressure response and adverse events.
• Polymorphisms in genes like angiotensinogen, angiotensin-converting enzyme (ACE), and angiotensin II type 1 receptor (AT1R) are linked to antihypertensive response.

Conclusions:

• Understanding the sources of HTE is crucial for interpreting research on hypertension therapies.
• Pharmacogenetic insights, especially concerning the RAAS, offer explanations for individual variations in treatment efficacy.
• Knowledge of HTE aids in designing tailored hypertension treatment protocols and evaluating patient responses.